Venture Capital

Rivian unveils the R2, a mid-size SUV starting around $45,000. It packs clever features and impressive range, but can the company scale production to meet demand?

The veteran cycling outfitter is launching guided hiking, paddling, and gourmet camping trips, tapping into a surging demand for accessible wilderness luxury.

Crusoe unveils its 'AI Factory' in a box, deploying high-performance, sovereign AI infrastructure anywhere in months, not years, shaking up the market.

South Korea's KORAD is turning a domestic necessity into a global export strategy, showcasing advanced radioactive waste technology on the world stage.

With $26M in new funding, BackOps is deploying an AI-native operating system to automate logistics and untangle complex global supply chains.

Kansas City's EverFast Fiber is partnering with GOCare, betting that a modern, digital-first customer experience is the key to winning a crowded market.

Defense disruptor Anduril is buying space-tracking firm ExoAnalytic, fusing a global telescope network with its AI to build next-gen national security systems.

ICSC's new proptech event aims to bridge the gap between tech founders and CRE leaders, signaling a major industry shift toward large-scale innovation.

Verily Me's AI 'Violet' promises personalized health advice, but a looming lawsuit raises serious questions about data privacy and user trust.

Known for smart vacuums, Dreame is storming the premium phone market with modular cameras, a luxury line, and a bold $1.38 billion R&D gamble.

Shoptalk's 2026 agenda reveals an industry grappling with its AI future, balancing algorithmic power with the essential need for human connection.

Amidst global challenges to open societies, a new online forum from the Institute for Humane Studies aims to defend and redefine liberalism for a new era.

A groundbreaking clinical trial shows a nutrition-based therapy extended life by 34% in stage IV pancreatic cancer patients, offering rare hope.

An Israeli tech firm's new compression technology promises to cut AI data storage by 50% without harming model accuracy, accelerating the future of AVs.

Backed by Goldman Sachs, ORO Labs is using AI orchestration to overhaul how giants like Coca-Cola and Novartis handle spending and compliance.

A $3M government-backed investment is fueling a new model for real estate innovation, merging profit with purpose to tackle housing and climate challenges.

A plant-based gel that stops severe bleeding in seconds is being showcased to top trauma experts, signaling a major shift in emergency medicine.

As AI's energy thirst strains grids, solid-state transformer pioneer DG Matrix hires marketing ace Rainer Stiller to scale its game-changing technology.

Genomic Testing Cooperative opens a Houston lab, leveraging the city's elite oncology ecosystem to expand its unique cooperative model for cancer testing.

Ratio Therapeutics appoints Dr. Colin Hayward as CMO, a strategic move to advance its sarcoma trial and challenge leaders in the booming radiopharmaceutical market.